Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Clinical trial NCT05917106 · RECRUITING

Trial details

NCT number: NCT05917106
Sponsor: Jinling Hospital, China
Status: RECRUITING
Study type: OBSERVATIONAL

Carcinoma Renal Cell Carcinoma RCC Kidney Neoplasms Kidney Cancer

Start date: 2022-12-26
Primary completion: 2028-06-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.